Most Viewed Articles - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Most Viewed Articles

US Science Advisors Issue Report on Innovation in Drug Discovery and Development

October 1, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

The President's Council of Advisors on Science and Technology (PCAST) released a report containing recommendations for boosting innovation in drug discovery and development.

EMA Aims to Facilitate Biosimilars Development

October 1, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

The European Medicines Agency has updated its guidance on biosimilar medicines, with the aim of helping companies to avoid unnecessary repetition of clinical trials.

Foaming Improves Drugs Made with Hot-Melt Extrusion

September 19, 2012

Equipment and Processing Report

Foaming can be used to improve processing in the extruder without the use of a plasticizer, facilitate milling, increase dissolution rates, and produce novel dosage forms.

J&J to Establish Innovation Centers

September 19, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

Johnson & Johnson has announced plans to open four innovation centers in California, Boston, London, and China, with the aim of accelerating early innovation and facilitating collaboration and investment opportunities.

Bayer HealthCare Acquires Teva's US Animal Health Business

September 18, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

Teva announced an agreement in which Bayer HealthCare will acquire the US-based animal health business of Teva Pharmaceutical Industries for up to $145 million. The transaction is expected to close in 2013, subject to antitrust clearance and other conditions.

Evaluating Market Opportunities in Orphan Drugs

September 5, 2012

PTSM: Pharmaceutical Technology Sourcing and Management

Although serving niche areas, orphan drugs offer good market opportunities for pharmaceutical companies and their suppliers.

Merck KGaA to Reduce 10% of its German Workforce

September 5, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

Merck KGaA has announced plans to eliminate 1100 jobs in Germany by the end of 2015—almost 10% of the company's 10,900 German positions.

Bristol-Myers Squibb Issues Voluntary Recall of Carmustine for Overfilled Vials

September 4, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

Bristol-Myers Squibb has initiated a voluntary recall of 10 lots of BiCNU (carmustine for injection) previously manufactured by Ben Venue Laboratories, a former, third-party contract manufacturer for the company, to the user level.

2,4,6-Tribromoanisole and 2,4,6-Trichloroanisole

September 2, 2012

Pharmaceutical Technology

A review of taints and odors in the pharmaceutical and consumer healthcare industries.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
Click here